Schering Korea to launch Zevalin for NHL cancer.

Schering Korea announced to launch Zevalin, a new drug for the treatment of non-Hodgkin's lymphoma, which was a rare cancer as widely known when the former first lady of the United States was struggling against. Zevalin is indicated for a slowly progressive follicle type of lymphoma as a first radiological immunotherapy.

Zevalin is a new concept of cancer therapy by binding a radio isotope,...